Both in Diagnostics
Cardio Diagnostics Holdings vs Myriad Genetics
Over the past year CDIO returned −59.8% and MYGN returned −26.2%; their daily moves had a correlation of 0.12.
CDIO −59.8% MYGN −26.2%Growth of $1, one year, split-adjusted
| Metric | CDIO | MYGN |
|---|---|---|
| Price | $1.60 | $6.04 |
| Market cap | $4.7M | $577.7M |
| Today | −4.19% | +3.25% |
| 1 month | −22.3% | +31.9% |
| 6 months | −12.6% | +20.1% |
| Year to date | −41.0% | −1.8% |
| 1 year | −60.4% | −24.9% |
| Revenue growth (YoY) | −28.3% | −10.5% |
| Gross margin | 100.0% | 66.6% |
| Net margin | −28012.5% | −22.7% |
| P/E (TTM) | — | — |
| Price / sales | 327.7× | 0.7× |
| Net cash | $5.6M | -$5.5M |
| Dividend yield | — | — |
| Volatility (60d) | 66.7% | 85.1% |
| Short % of float | 0.1% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).